Copyright Reports & Markets. All rights reserved.

Global Nociceptin Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Nociceptin Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Nociceptin Receptor Market Size Growth Rate by Product
      • 1.4.2 AT-403
      • 1.4.3 BTRX-246040
      • 1.4.4 Cebranopadol
      • 1.4.5 GRT-6010
      • 1.4.6 GRTTA-2210
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Nociceptin Receptor Market Size Growth Rate by End User
      • 1.5.2 Diabetic Neuropathic Pain
      • 1.5.3 Drug Addiction
      • 1.5.4 Major Depressive Disorder
      • 1.5.5 Postherpetic Neuralgia
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Nociceptin Receptor Market Size
      • 2.1.1 Global Nociceptin Receptor Revenue 2014-2025
      • 2.1.2 Global Nociceptin Receptor Sales 2014-2025
    • 2.2 Nociceptin Receptor Growth Rate by Regions
      • 2.2.1 Global Nociceptin Receptor Sales by Regions
      • 2.2.2 Global Nociceptin Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Nociceptin Receptor Sales by Manufacturers
      • 3.1.1 Nociceptin Receptor Sales by Manufacturers
      • 3.1.2 Nociceptin Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Nociceptin Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nociceptin Receptor Revenue by Manufacturers
      • 3.2.1 Nociceptin Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nociceptin Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Nociceptin Receptor Price by Manufacturers
    • 3.4 Nociceptin Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Nociceptin Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Nociceptin Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Nociceptin Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Nociceptin Receptor Sales by Product
    • 4.2 Global Nociceptin Receptor Revenue by Product
    • 4.3 Nociceptin Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Nociceptin Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Nociceptin Receptor by Countries
      • 6.1.1 North America Nociceptin Receptor Sales by Countries
      • 6.1.2 North America Nociceptin Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Nociceptin Receptor by Product
    • 6.3 North America Nociceptin Receptor by End User

    7 Europe

    • 7.1 Europe Nociceptin Receptor by Countries
      • 7.1.1 Europe Nociceptin Receptor Sales by Countries
      • 7.1.2 Europe Nociceptin Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Nociceptin Receptor by Product
    • 7.3 Europe Nociceptin Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Nociceptin Receptor by Countries
      • 8.1.1 Asia Pacific Nociceptin Receptor Sales by Countries
      • 8.1.2 Asia Pacific Nociceptin Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Nociceptin Receptor by Product
    • 8.3 Asia Pacific Nociceptin Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Nociceptin Receptor by Countries
      • 9.1.1 Central & South America Nociceptin Receptor Sales by Countries
      • 9.1.2 Central & South America Nociceptin Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Nociceptin Receptor by Product
    • 9.3 Central & South America Nociceptin Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Nociceptin Receptor by Countries
      • 10.1.1 Middle East and Africa Nociceptin Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Nociceptin Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Nociceptin Receptor by Product
    • 10.3 Middle East and Africa Nociceptin Receptor by End User

    11 Company Profiles

    • 11.1 Blackthorn Therapeutics Inc
      • 11.1.1 Blackthorn Therapeutics Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Blackthorn Therapeutics Inc Nociceptin Receptor Products Offered
      • 11.1.5 Blackthorn Therapeutics Inc Recent Development
    • 11.2 Fuso Pharmaceutical Industries Ltd
      • 11.2.1 Fuso Pharmaceutical Industries Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Products Offered
      • 11.2.5 Fuso Pharmaceutical Industries Ltd Recent Development
    • 11.3 Grunenthal GmbH
      • 11.3.1 Grunenthal GmbH Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Grunenthal GmbH Nociceptin Receptor Products Offered
      • 11.3.5 Grunenthal GmbH Recent Development
    • 11.4 Orexigen Therapeutics Inc
      • 11.4.1 Orexigen Therapeutics Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Orexigen Therapeutics Inc Nociceptin Receptor Products Offered
      • 11.4.5 Orexigen Therapeutics Inc Recent Development
    • 11.5 Serodus ASA
      • 11.5.1 Serodus ASA Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Serodus ASA Nociceptin Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Serodus ASA Nociceptin Receptor Products Offered
      • 11.5.5 Serodus ASA Recent Development

    12 Future Forecast

    • 12.1 Nociceptin Receptor Market Forecast by Regions
      • 12.1.1 Global Nociceptin Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Nociceptin Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Nociceptin Receptor Market Forecast by Product
      • 12.2.1 Global Nociceptin Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Nociceptin Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Nociceptin Receptor Market Forecast by End User
    • 12.4 North America Nociceptin Receptor Forecast
    • 12.5 Europe Nociceptin Receptor Forecast
    • 12.6 Asia Pacific Nociceptin Receptor Forecast
    • 12.7 Central & South America Nociceptin Receptor Forecast
    • 12.8 Middle East and Africa Nociceptin Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Nociceptin Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Nociceptin Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nociceptin Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Nociceptin Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nociceptin Receptor in these regions.
      This research report categorizes the global Nociceptin Receptor market by top players/brands, region, type and end user. This report also studies the global Nociceptin Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Blackthorn Therapeutics Inc
      Fuso Pharmaceutical Industries Ltd
      Grunenthal GmbH
      Orexigen Therapeutics Inc
      Serodus ASA

      Market size by Product
      AT-403
      BTRX-246040
      Cebranopadol
      GRT-6010
      GRTTA-2210
      Others
      Market size by End User
      Diabetic Neuropathic Pain
      Drug Addiction
      Major Depressive Disorder
      Postherpetic Neuralgia
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Nociceptin Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Nociceptin Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Nociceptin Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Nociceptin Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Nociceptin Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nociceptin Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now